The Rifaximin 550 mg Tablets Finish Product Complete Testing Procedure, like other pharmaceutical products, is essential to ensure their safety, efficacy, and quality. Below is an overview of the typical testing procedures involved in the production and quality control of Rifaximin tablets.
The goal of these testing procedures is to ensure that Rifaximin 550 mg tablets are safe, effective, and of high quality, providing patients with the expected therapeutic benefits while minimizing risks and maintaining product consistency.
Please note that specific testing procedures may vary depending on the country, regulatory agency, and pharmaceutical company. Manufacturers must adhere to good manufacturing practices (GMP) to maintain the quality and consistency of their products.
To describe the procedure for analysis at the in-process and finished stage of Rifaximin 550 mg Tablet.
This SAP gives a detailed outline for the finished product analysis of Rifaximin 550 mg Tablet and will cover process testing activities on a physical, chemical & instrumental basis.
QC Analyst is responsible for physical/chemical testing and preparing standard analytical procedures.
It is the responsibility of the QC Manager to assist and ensure the Testing Procedure as per SAP
and to make certain that this SAP is followed in its entirety, reviewed regularly, and revised as necessary.
MATERIAL AND EQIUPMENT:
- UV Spectrophotometer
- Dissolution apparatus
- Friability apparatus
- Hardness apparatus
- Disintegration Tester
- Vernier Caliper
- Analytical Balance
- Moisture analyzer
- Mortar and pestle
- Filter Paper
- Magnetic Stirrer & Hot Plate
- Vacuum Pump
- Sodium dihydogen phosphate
- Sodium hydrogen phosphate
- Sodium lauryl sulfate
- Distilled water
A granular powder.
Procedure: Take 2.0 g of the test sample in a watch glass and observe visually with black background. Check the appearance of color, nature and any visible foreign particles.
Loss on Drying: (By Moisture Analyzer)
Turn on instrument 20 minute before the test. Take 2 g powder spread uniformly on Moisture analyzer plate. Close the lid and press start button.
NMT 5.0% when determined by LOD Apparatus, Use 2.0 g of powder.
Identification: (By UV SPECTROPHOTOMETER)
The spectrum of the sample preparation corresponds to spectrum of the standard preparation as obtained in the assay.
ASSAY (By UV SPECTROPHOTOMETER)
Assay: (Limit: 90%-110%) Compression Weight of Powder/Tablet:…….
Diluent: (Ethanol: Water, 20:80)
Take 30 mg of Rifaximin WS dissolved in diluent and make up the volume to 50mL with diluent. Shake, and sonicate for 5 minutes to facilitate dissolution
Take 2 mL from standard stock solution and make up the volume to 50 mL with water.
Take 5gram of sample grind them to fine powder. Take compression weight of finally grinded powder equivalent to 30mg Rifaximin and dissolved in diluent and make up the volume to 50mL with diluent. Shake by mechanical mean for 10 minutes to disperse and allow any insoluble matter to settle.
Pass a portion of the sample stock solution through a suitable filter of 0.45um pore size.
Transfer the 2 mL of filtrate to a 50 mL volumetric flask make up volume with water. Take reading at UV spectrophotometer at 293 nm using diluent as blank.
Sample Absorbance x Standard Concentration x Ave. Weight of Tablet x Potency
Standard Absorbance x Sample Concentration x Label Claim
Limit: Rifaximin: 90%-110%of the labeled amount
Uniformity of Dosage Units: (By Weight Variation)
Weigh 20 tablets individually and calculate the average weight as:
Average weight = (Weight Of 20 Tablets)/20
Weigh all these tablets individually and mark among these weights maximum (WMax) & minimum (WMin) weight tablets. Calculate the maximum and minimum variation in percent as:
Maximum% age variation =((WMax) – (WAvg.))/WAvg×100
Minimum % age variation ((WMin) – (WAvg.))/WAvg×100
Hardness Test & Dimensions:
Perform the hardness test on 10 tablets and take the average. Power on the instrument and regulate zero adjustment and preset the ‘’HARDNESS’’ and “Thickness” mode. Place the tablet on the test plate, begin testing and read the hardness thickness and diameter. Clean the shattered tablet and print out test results, perform the test on 10 tablets and take the average.
Hardness Standard Limit:……
Length/Diameter Standard Limit:…..
Thickness Standard Limit:…….
Width Standard Limit:……
For tablets with a unit mass equal to or less than 650 mg, take a sample of whole tablets corresponding to 6.5 g. For tablets with a unit mass of more than 650 mg, take a sample of 10 whole tablets. The tablets should be carefully dedusted prior to testing. Accurately weigh the tablet sample, and place the tablets in the drum. Rotate the drum 100 times, and remove the tablets. Remove any loose dust from the tablets as before, and accurately weigh. Generally, the test is run once. If obviously cracked, cleaved, or broken tablets are present in the tablet sample after tumbling, the sample fails the test. If the results are doubtful or if the weight loss is greater than the targeted value, the test should be repeated twice and the mean of the three tests determined. A maximum mean weight loss from the three samples of not more than 1.0% is considered acceptable for most products.
% FRIABILITY= W1-W2 x 100 / W1
Place the beaker filled with water into the beaker stand inside the bath and. Switch on the instrument, set the temperature at 37ºC ± 2º C and wait till the temperature of the beaker reaches to the 37ºC± 2ºC. Engage the basket on basket hook put the tablets in 6 tubes individually and place the discs then start the oscillations and timer. Note the disintegration time of all the six tablets.
Note the Disintegration time of 1st tablet to the last tablet.
Disintegration Time: NMT 15 minutes at 370C ± 20C
Acceptance criteria of disintegration for tablets:
If 1 or 2 tablets fail to disintegrate completely repeat the test on 12 additional tablets, not less than 16 of the totals of 18 tablets tested disintegrate completely.
Take 06 blisters of tablet 03 filled and 03 empty. Dip these blisters in the bowl of leak test apparatus containing colored water. Create vacuum 250 mmHg and hold for one minute. Release vacuum and check the penetration of water inside the blisters. All blisters should be free of water.
Preparation of Phosphate Buffer pH 7.40:
Dissolve 3.1 g of sodium dihydogen phosphate (NaH2PO4.H2O) ±10.9 g of Sodium hydrogen phosphate) NaHPO4and 0.8 g of sodium lauryl sulfate dissolved in 1000 mL of water. Add water and volume make up up to 1000 mL with Water. Adjust with phosphoric acid or 1M NaOH to a pH of 7.40, if necessary.
USP Apparatus: USP Apparatus II Peddle
Medium: 1000mL 0.1M sodium phosphate buffer pH 7.4 containing 0.8% Sodium Lauryl Sulfate
Speed: 75 rpm
Time: 90 Minute
Medium Temperature: 37º ± 0.5º
Recommended Sampling Time: Rifaximin: 90 Minutes
Diluent: Dissolution medium
Take 27.5 mg Rifaximin WS in 50 mL volumetric flask add medium to dissolve Rifaximin then make up volume with medium.
Take 2 mL from standard stock solution and make up the volume up to 50 mL with medium.
Pass a portion of solution under through a suitable filter of 0.45-um pore size.
Take 2 mL from sample filtrate and make up the volume up to 50 mL with medium.
Analytical wavelength: UV 293 nm
Sample Absorbance x Standard Concentration x Potency
Standard Absorbance x Sample Concentration
The amount of drug dissolve in solution for each tablet is not less Than 80% Q of the amount stated on the label for Rifaximin at 90 minutes.